Clinical Trials for Pancreatic Adenocarcinoma

68Ga-FAPI-46 in Staging of Pancreatic Adenocarcinoma

NCT ID: NCT06911021

This clinical trial is exploring a new imaging technique called 68Ga-FAPI-46 PET/CT to help doctors better understand pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC). Tradit...

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

NCT ID: NCT06115499

The PLATINUM Trial is a clinical study looking at how effective a new chemotherapy treatment is for patients with advanced pancreatic cancer that has spread to other parts of the body. Specifically...

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

NCT ID: NCT06893536

This clinical trial is studying how nutritional issues affect patients with pancreatic cancer (specifically pancreatic adenocarcinoma) before and after surgery. Many patients in this situation may ...

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients with Locally Advanced Pancreatic Adenocarcinoma (LAPC)

NCT ID: NCT06217666

This clinical trial is looking at a new treatment for patients with locally advanced pancreatic cancer, which is a type of cancer that has spread but is still near the original site. The study aims...

Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

NCT ID: NCT05776342

This clinical trial is focused on understanding how well different treatments, like surgery and chemotherapy, work for patients with pancreatic adenocarcinoma, a type of pancreatic cancer. The rese...

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

NCT ID: NCT04605913

This clinical trial is exploring a new treatment approach for patients with metastatic pancreatic cancer, which means the cancer has spread beyond the pancreas to other parts of the body. The study...

9-ING-41 Combined with Retifanlimab, Plus Modified FOLFIRINOX for Patients with Advanced Pancreatic Adenocarcinoma (RiLEY)

NCT ID: NCT06896188

The RiLEY clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer that has not been treated before with standard therapies. This trial combines three treatm...

Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma

NCT ID: NCT06892054

This clinical trial is studying a new treatment approach for advanced pancreatic cancer that has a specific genetic change known as the KRAS p.G12C mutation. The trial will examine how safe it is t...

Naptumomab Estafenatox in Combination with Durvalumab in Subjects with Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT ID: NCT03983954

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic solid tumors, including types of cancer such as breast, ovarian, pancreatic, and esophageal ca...

Pilot Study of EUS-Guided Radiofrequency and FOLFIRINOX in Advanced Pancreatic Cancer (RadioFAP )

NCT ID: NCT06743386

This clinical trial, called the RadioFAP study, is looking at a new treatment approach for patients with advanced pancreatic cancer, a type of cancer that is very difficult to treat and often diagn...

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

NCT ID: NCT06867172

This clinical trial is investigating the prevalence of pancreatic steatosis, which means fat build-up in the pancreas, in patients with certain types of pancreatic cysts and pancreatic adenocarcino...

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

NCT ID: NCT06157671

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

NCT ID: NCT06412510

This clinical trial is studying a program designed to help patients prepare for cancer surgery. It focuses on whether an exercise and nutrition plan can help people with advanced ovarian cancer or ...

Study of LP-184 in Patients With Advanced Solid Tumors

NCT ID: NCT05933265

This clinical trial is investigating a new treatment called LP-184 for patients with advanced solid tumors, which are cancers that have spread and are not responding to standard therapies. The main...

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

NCT ID: NCT05988918

This clinical trial is studying a new drug called ESK981 in patients with certain types of advanced cancer, including pancreatic cancer and specific neuroendocrine tumors. The goal is to see how we...

Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

NCT ID: NCT03080974

This clinical trial is exploring a new treatment for patients with advanced pancreatic cancer, specifically looking at how well a combination of a procedure called irreversible electroporation and ...

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT ID: NCT06399757

This clinical trial is investigating a new treatment called APL-5125 for adults with advanced solid tumors, specifically focusing on types like colorectal cancer, pancreatic cancer, and triple-nega...

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

NCT ID: NCT03384238

This clinical trial is studying a new approach to help surgeons find pancreatic cancer during surgery. Researchers are testing a special drug called panitumumab-IRDye800, which combines a cancer-ta...

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

NCT ID: NCT06750861

This clinical trial is studying a new treatment option for patients with advanced pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC) that cannot be surgically removed. The trea...

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer

NCT ID: NCT05657743

This clinical trial is exploring a new treatment option for patients with advanced pancreatic cancer that cannot be surgically removed, known as unresectable pancreatic cancer. Researchers are test...